Blood and Marrow Transplantation and Cellular Therapy

Faculty in UNMC's division of oncology and hematology are pioneers in blood and marrow transplantation and cellular therapy.

Our renowned doctors, researchers and educators improve patient outcomes through clinical research, provide excellent patient care, and train the next generation of physicians.

[ PHOTO - close up someone pipetting or other appropriate work in lab?]

““All of this is the wave of the future. Our cellular therapy program is going to be at the cutting edge over the years, and we hope to continue to grow it exponentially.” ”

Julie Vose, MD

Chief of the Division of Hematology and Oncology

Blood and Bone Marrow Transplant Program

The blood and bone marrow transplant program has been ranked as one of the busiest adult and pediatric stem cell transplant programs in the world. The program averages 150 transplants a year since its inception in 1983.

Conditions treated includ:

leukemia and lymphoma
myeloma and other hematologic cancers
pediatric solid tumors like neuroblastoma or select brain tumors
immune deficiencies like SCID
metabolic diseases
non-malignant hematologic disorders like sickle cell anemia.

Our world-renowned experts:

Pioneer ground-breaking advancements, improving success rates and making blood and bone marrow transplants a viable option for more patients.
Specialize in disease-specific areas and give quality, continuous care through pre-transplant, transplant and recovery.
Are active in research and clinical trials so that we have access to the most up-to-date and revolutionary treatments. We are part of the National Institutes of Health/National Cancer Institute Blood and Marrow Transplant Clinical Trials Network and have clinical research trials underway.

Learn more

Cellular Transplant Program

Similar info about cellular transplant program

Our world-renowned experts:

Learn more

Program Experts

Vijaya Raj Bhatt, MBBS, MS

Professor, UNMC Division of Oncology & Hematology
Medical Director, Leukemia Program
Section Leader, Malignant Hematology
Co-Leader, Cancer Prevention and Control Program

Krishna Gundabolu, MBBS, MS

Associate Professor, UNMC Division of Hematology & Oncology
MPN, BMT, Coagulation Disorders & Non-Malignant Hematology

Matthew Lunning, DO, FACP

Assistant Vice Chancellor of Clinical Research
Associate Vice Chair of Research, UNMC Department of Internal Medicine
Professor, UNMC Division of Oncology & Hematology
Non-Hodgkin Lymphoma, Hodgkin Disease, Multiple Myeloma, CAR-T/Cellular Therapy, Benign Hematology

Julie M. Vose, MD, MBA

George and Peggy Payne Distinguished Chair of Oncology
Chief, UNMC Division of Oncology & Hematology
Professor, UNMC Division of Oncology & Hematology
Non-Hodgkin Lymphoma, Hodgkin Disease, Multiple Myeloma, Chronic Lymphocytic Leukemia

[ LINK TO SEPARATE FELLOWSHIP PAGE - TO BE DEVELOPED - WITH THE INFO BELOW]

We offer a Hematopoietic Cell Transplantation and Cellular Therapy fellowship for physicians who finished an ACGME accredited hematology fellowship and wish to pursue a career in blood and marrow transplantation and cellular therapy.